Standard deviation of dissolution results exceeds acceptable limits.

Customer Complaints: Reports of product efficacy issues from distribution channels which point back to dissolution performance.

Recognizing these signs promptly is critical to initiating the containment and corrective action processes effectively.

Likely Causes

Dissolution failures during site-to-site transfers can stem from multiple categories of causes. A systematic exploration of these elements can help identify the root of the problem:

Category	Likely Causes
Materials	Differences in excipients, sourcing variations, or alterations in API quality.
Method	Changes in dissolution methodologies or variations in equipment calibrations.
Machine	Differences in equipment performance or maintenance between sites affecting dissolution.
Man	Operator errors during sample preparation or testing procedures.
Measurement	Variability due to measurement techniques or analytical validations misalignments.
Environment	Variations in humidity, temperature, or atmospheric conditions affecting drug solubility.

This categorization builds a framework for understanding potential failure sources and guiding immediate follow-up actions for remediation.

Immediate Containment Actions (first 60 minutes)

Upon identification of a dissolution failure, it is crucial to act swiftly to contain potential fallout. Immediate actions include:

1. Cease Product Release: Temporarily halt the release of affected batches to prevent distribution of non-compliant products.
2. Isolate Affected Batches: Mark and quarantine all related materials and products pending investigation outcomes to ensure traceability.
3. Notify Key Stakeholders: Engage quality, manufacturing, and regulatory teams early to instill urgency in the investigation process.
4. Conduct Preliminary Assessments: Review preliminary dissolution results and define potential variables for immediate verification.
5. Document All Actions: Initiate a deviation report and document each step taken to ensure a thorough audit trail.

Implementing these steps rapidly can mitigate risks before they escalate into larger compliance issues.

Investigation Workflow (data to collect + how to interpret)

The investigation into dissolution failures should follow a structured workflow to gather relevant data and guide effective decision-making. Steps to follow include:

1. Collect Dissolution Data: Document results from all affected batches, including unit variances and historical data comparisons.
2. Review Manufacturing Records: Analyze batch manufacturing records to identify any deviations or anomalies in the process.
3. Examine Equipment Calibration: Ensure all testing equipment is calibrated according to established biopharmaceutical standards.
4. Operator Feedback: Gather insights from operators involved in both production and testing to capture contextual issues.
5. Material Traceability: Validate the identity and quality of materials used, tracing back to the receiving site practices and protocols.

Once data collection is complete, interpreting the collected information can hone in on the essential variables that contributed to the failure.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Applying root cause analysis tools effectively is vital for pinpointing dissolution failure sources:

• 5-Why Analysis: Utilize this method for straightforward failures where you can trace cause-and-effect relationships efficiently. By asking “why” repeatedly, you push through layers of symptoms to reveal root causes.
• Fishbone Diagram: Employ this tool when dealing with multifactorial issues. It visualizes potential causes categorized by the 6 M’s: Man, Machine, Material, Method, Measurement, and Environment, facilitating team brainstorming.
• Fault Tree Analysis: Use this for complex systems or when multiple contributing factors may be at play. It enables a logical deduction from failure outcomes to their root causes based on a tree structure.

Choosing the appropriate tool based on complexity ensures a clearer path to identifying the underlying problems.

CAPA Strategy (correction, corrective action, preventive action)

Following the identification of root causes, establishing a robust CAPA strategy is crucial for rectification and future prevention:

1. Correction: Fix the immediate issue by revising the dissolution testing protocol or recalibrating the equipment used.
2. Corrective Actions: Implement changes in the manufacturing practices or site transfer guidelines to address the findings uncovered through the investigation (e.g., revisiting sourcing standards).
3. Preventive Actions: Develop standard operating procedures (SOPs) for future site transfers, incorporating insights and additional controls, thus minimizing risk of recurrence.

Documenting these actions clearly in your quality management system supports further audits and regulatory review processes.

Related Reads

• Tech Transfer Delays and Scale-Up Failures? Practical Solutions From Lab to Commercial
• Pharmaceutical Manufacturing Scale-Up & Tech Transfer – Complete Guide

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

Establishing a solid control strategy post-failure is essential in enhancing process capability. Key components include:

• Statistical Process Control (SPC): Implement SPC charts to monitor dissolution variability over time, employing control limits to catch shifts or trends proactively.
• Regular Sampling: Ensure robust sampling plans are in place for both incoming materials and in-process controls through the dissolution testing stages.
• Alarm Systems: Configure alarms for critical limits within dissolution equipment to trigger alerts for any significant deviation.
• Verification Processes: Conduct routine verifications to confirm adherence to updated SOPs and protocols for dissolution testing.

By robustly monitoring these outputs, firms can proactively manage risks associated with dissolution failures.

Validation / Re-qualification / Change Control impact (when needed)

A dissolution failure can trigger a re-evaluation of validation protocols, potentially impacting change control and associated documentation. Consider the following:

• Validation Review: Re-assess and re-validate any test methods and equipment affected by identified failures.
• Re-qualification of Equipment: Confirm that dissolution testing equipment, particularly if moved or adjusted as part of a transfer, remains in validated status.
• Alteration in Change Control Processes: Implement changes in the change management system to include contingencies for potential dissolution discrepancies in future site-to-site transfers.

This review process strengthens organizational integrity and compliance alignment with industry standards.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

When preparing for an inspection post-failure, evidence collection is vital to demonstrate compliance:

• Batch Documentation: Ensure completeness of all batch records, highlighting any deviations and corrective measures taken.
• Logs and Records: Maintain a detailed log of testing results, investigation data, and CAPA actions, demonstrating a systematic approach to the dissolution failure.
• Documented Procedures: Ensure all SOPs include updates based on lessons learned from the incident.
• Training Records: Provide records showing proper training of staff involved in dissolution tests under new protocols.

Having thorough records available can enhance inspection readiness and build trust in your quality system.

FAQs

What are common symptoms of dissolution failure?

Common symptoms include inconsistent dissolution profiles, OOS results, increased variability in testing, and customer complaints regarding product efficacy.

How can I contain dissolution failures immediately?

Immediate containment actions include halting release of affected batches, quarantining materials, notifying stakeholders, and initiating preliminary assessments.

What root cause analysis tools should I use?

Use the 5-Why analysis for simple issues, the Fishbone diagram for multifactorial issues, and Fault Tree analysis for complex systems.

What are the key components of a CAPA plan?

A CAPA plan should include correction, corrective actions, and preventive actions to address the immediate failure and prevent recurrence.

How can I establish a control strategy after a failure?

Implement SPC, regular sampling, alarm systems for critical limits, and verification processes to monitor and validate the dissolution process.

When should I consider re-validation after a failure?

Re-validation may be necessary when there are changes to trial methods, equipment, or following significant deviations in testing results.

What documentation is essential for inspection readiness?

Essential documentation includes batch records, testing logs, CAPA documentation, SOPs, and training records related to dissolution processes.

What are the regulatory implications of dissolution failures?

Regulatory implications can include increased scrutiny during inspections, potential recalls, and impacts on product approvals depending on severity and frequency of failures.